|
ISPE Events
Guidance Documents
Training
Pharmaceutical Engineering Magazine
eLearning
Publications
Glossary
|
Young Professionals
Affiliates and Chapters
Advertise/Exhibit
Communities of Practice
Regulators
Volunteers
Students
International Leadership Forum
|
CPIP - Professional Certification
Employers
Job Seekers
|
Product Quality Lifecycle Implementation® (PQLI®) 101: Vision, Status and Next Steps
Format:Recorded Webinar
Duration: 45 minutes
Member Fee: FREE: View Now 
Non-Member Fee: US$ 49: View
Now
Note: Webinar files may be very large and may take a while to display.
Presenter
- Christopher Potter, CMC consultant and Technical Project Manager for ISPE’s PQLI® Initiative
How You Will Benefit
At the conclusion of this session, participants will be able to:
- Understand the history of PQLI
- Describe why it is an important initiative and how the industry can benefit from it
- Know how to get involved
Description
An overview of ISPE’s Product Quality Lifecycle Implementation® (PQLI®) initiative is provided, including its history, progress, and where it is heading. The PQLI initiative was created to provide guidance on practical implementation of the concepts described in ICH guidelines, focusing on Q8, Q9, Q10 and the future Q11to help ensure product quality throughout a product lifecycle, leading to continuous product improvement.
Who Should Participate
Any industry professional in a quality discipline.
PQLI has something for virtually everyone from scientists involved in chemical process development and analysis, formulation and packaging development and analysis, CMC project management, technology transfer, validation, CMC regulatory, compliance, manufacturing, quality control, quality assurance, process control, engineering, biotech process development and analysis.
Presenter Biography
Christopher Potter has BSc and PhD degrees in organic chemistry and has worked for three companies holding senior management positions in CMC pharmaceutical and analytical development, and quality/compliance. Potter was a member of EFPIA’s ad hoc Quality Group from 1996 to 2007, and during this period was EFPIA topic leader for ICHQ6A, Specifications for New Drug Substances and New Drug Products, and ICH Q4B, Regulatory Acceptance of Pharmacopoeial Interchangeability. Potter retired from AstraZeneca and is working as a CMC consultant as well as project managing ISPE’s Product Quality Lifecycle Implementation (PQLI) initiative.
Related Communities of Practice (COPs)
API, Biotech, GCLP, IP, Packaging, PAT, PPD, PM, and SPP
More information on Communities of Practice (COPs)
Related articles:
- PQLI Articles June 2008 issues of JPI
- John Berridge’s editorial in March 2009 issue of JPI
- Christopher Potter and his team’s paper on Application of Science- and Risk-based Approaches (Q8, Q9 and Q10) to Existing Products in March 2009 issue of JPI
Indicates content available to ISPE members only.
My ISPE
